McKesson Medical-Surgical, one of the largest medical supplies distributors in the country, is a subsidiary of Irving-based ...

McKesson (MCK) delivered earnings and revenue surprises of 2.61% and 4.66%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?

McKesson (MCK – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst Allen Lutz ...

Steve Baxter, an analyst from Wells Fargo, maintained the Hold rating on McKesson (MCK – Research Report). The associated price target ...

The health-tech industry’s long-term growth is fueled by the growing need for cutting-edge technologies to address critical ...

Outside the us market, McKesson engages in pharmaceutical wholesale and distribution in Canada. Additionally, the company ...

Fintel reports that on November 7, 2024, Baird upgraded their outlook for McKesson (NYSE:MCK) from Neutral to Outperform. ...

As of fiscal year-end 2024, McKesson had a cash and cash equivalents balance of $4.6 billion with an outstanding debt balance of $5.6 billion. Roughly one third of its debt is due to mature over the ...

McKesson's second-quarter fiscal 2025 results showcase growth in the U.S. Pharmaceutical segment. However, Medical Surgical ...

Chicago Partners Investment Group LLC increased its stake in shares of McKesson Co. (NYSE:MCK – Free Report) by 17.0% during ...

It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions ...